EXPEDITE HEALTH LIMITEDActive

Company number 09232839Private limited companyIncorporated 2014
⚠ Confirmation statement overdue. It was due on 8 Oct 2026.

Key figures

£428,245+6.5%
Net assets 2024/25
+19.6%
Average annual growth 2019/20–2024/25
0200 k400 k600 k2019/202020/212022/232023/242024/25

Like most small UK companies, EXPEDITE HEALTH LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0200 k400 k600 k2019/202020/212022/232023/242024/25
Filed accounts2019/20–2024/25
2019/202020/212022/232023/242024/25
Cash at bank and in hand171,814229,178355,411359,045394,943
Total assets242,112301,298419,747451,783476,338
Total liabilities—46,70048,93852,40452,480
Net assets / total equity209,136252,929374,384402,060428,245
Average number of employees33-3-33

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: EXPEDITE HEALTH LIMITED

Company

EXPEDITE HEALTH LIMITED is a private limited company registered with Companies House under company number 09232839. It was incorporated on 24 Sep 2014. Its status is active. The registered office is in Ripon (HG4). Its nature of business (SIC 2007) is general medical practice activities (86210).

Accounts

The latest accounts in the database are for 2024/25 (period ending 30 Sep 2025); the company files small company accounts (filleted). Net assets were £428,245, up 6.5% on the previous year. Cash at bank and in hand was £394,943. Total assets were £476,338 and total liabilities £52,480. The company had an average of 3 employees. Figures are available for 5 financial years (2019/20–2024/25).

Control and charges

2 persons with significant control are registered.

Filing deadlines

The next accounts are due by 30 Jun 2027. The next confirmation statement is due by 8 Oct 2026.